ATRA Atara Biotherapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRA

Price (delayed)

$0.7225

Market cap

$86.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.61

Enterprise value

$140.57M

Atara Biotherapeutics, Inc.(@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers ...

Highlights
The debt has decreased by 9% YoY
Atara Biotherapeutics's gross margin has shrunk by 104% YoY but it has surged by 86% QoQ
The gross profit has plunged by 100% YoY but it has soared by 74% from the previous quarter
The equity has dropped by 178% year-on-year and by 95% since the previous quarter
Atara Biotherapeutics's quick ratio has shrunk by 83% YoY and by 54% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.atarabio.com
Peers: AMGN HRTX LIFE AGEN

Key stats

What are the main financial stats of ATRA
Market
Shares outstanding
119.36M
Market cap
$86.24M
Enterprise value
$140.57M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
8.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.4
Earnings
Revenue
$8.57M
EBIT
-$270.83M
EBITDA
-$254.2M
Free cash flow
-$194.18M
Per share
EPS
-$2.61
Free cash flow per share
-$1.83
Book value per share
-$0.97
Revenue per share
$0.08
TBVPS
$1.56
Balance sheet
Total assets
$165.5M
Total liabilities
$264.74M
Debt
$80.32M
Equity
-$99.23M
Working capital
-$40.36M
Liquidity
Debt to equity
-0.81
Current ratio
0.72
Quick ratio
0.6
Net debt/EBITDA
-0.21
Margins
EBITDA margin
-2,965.1%
Gross margin
-3.7%
Net margin
-3,220.9%
Operating margin
-3,219.5%
Efficiency
Return on assets
-122.3%
Return on equity
N/A
Return on invested capital
-158.1%
Return on capital employed
-1,163.4%
Return on sales
-3,159.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRA stock price

How has the Atara Biotherapeutics stock price performed over time
Intraday
1.76%
1 week
1.36%
1 month
21.31%
1 year
-75.59%
YTD
40.89%
QTD
4.11%

Financial performance

How have Atara Biotherapeutics's revenue and profit performed over time
Revenue
$8.57M
Gross profit
-$313,000
Operating income
-$276.01M
Net income
-$276.13M
Gross margin
-3.7%
Net margin
-3,220.9%
Atara Biotherapeutics's gross margin has shrunk by 104% YoY but it has surged by 86% QoQ
The gross profit has plunged by 100% YoY but it has soared by 74% from the previous quarter
Atara Biotherapeutics's revenue has surged by 89% QoQ but it has shrunk by 87% YoY
The net margin has increased by 50% from the previous quarter

Growth

What is Atara Biotherapeutics's growth rate over time

Valuation

What is Atara Biotherapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
8.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.4
The EPS has decreased by 17% YoY but it has increased by 6% from the previous quarter
The equity has dropped by 178% year-on-year and by 95% since the previous quarter
Atara Biotherapeutics's revenue has surged by 89% QoQ but it has shrunk by 87% YoY
ATRA's P/S is 50% below its last 4 quarters average of 17.7

Efficiency

How efficient is Atara Biotherapeutics business performance
The company's return on assets has shrunk by 111% YoY and by 17% QoQ
Atara Biotherapeutics's return on invested capital has shrunk by 101% YoY and by 24% QoQ
The ROS has increased by 50% from the previous quarter

Dividends

What is ATRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRA.

Financial health

How did Atara Biotherapeutics financials performed over time
The total assets is 37% less than the total liabilities
Atara Biotherapeutics's quick ratio has shrunk by 83% YoY and by 54% QoQ
Atara Biotherapeutics's current ratio has plunged by 81% YoY and by 52% from the previous quarter
The debt is 181% more than the equity
The equity has dropped by 178% year-on-year and by 95% since the previous quarter
ATRA's debt to equity is up by 50% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.